Company profile
Ticker
QDEL
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Coronado Topco, Inc.
SEC CIK
Corporate docs
Subsidiaries
Ortho-Clinical Diagnostics Australia Pty Ltd. • Ortho-Clinical Diagnostics GmbH • Ortho-Clinical Diagnostics FinCo S.a.r.l. • Ortho-Clinical Diagnostics NV • Ortho Clinical Diagnostics Do Brasil Produtos Para Saude Ltda. • 10165 McKellar Court, L.P. • Immutopics, Inc. • QuidelOrtho Canada Corporation • Quidel China, Ltd. • Ortho-Clinical Diagnostics Trading (China) Co. Ltd. ...
Latest filings (excl ownership)
SD
Conflict minerals disclosure
30 May 24
8-K
Submission of Matters to a Vote of Security Holders
17 May 24
8-K
QuidelOrtho Reports First Quarter 2024 Financial Results
8 May 24
8-K
QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer
7 May 24
8-K
Entry into a Material Definitive Agreement
29 Apr 24
ARS
2023 FY
Annual report to shareholders
2 Apr 24
DEFA14A
Additional proxy soliciting materials
2 Apr 24
DEF 14A
Definitive proxy
2 Apr 24
8-K/A
Departure of Directors or Certain Officers
29 Feb 24
10-K
2023 FY
Annual report
29 Feb 24
Transcripts
QDEL
Earnings call transcript
2024 Q1
8 May 24
QDEL
Earnings call transcript
2023 Q4
13 Feb 24
QDEL
Earnings call transcript
2023 Q3
1 Nov 23
QDEL
Earnings call transcript
2023 Q2
8 Aug 23
QDEL
Earnings call transcript
2023 Q1
3 May 23
QDEL
Earnings call transcript
2022 Q4
15 Feb 23
QDEL
Earnings call transcript
2022 Q3
3 Nov 22
Latest ownership filings
4
Change in insider ownership
26 Jul 24
4
Change in insider ownership
24 Jul 24
SC 13D/A
Carlyle Group Inc.
24 Jul 24
4
KENNETH J WIDDER
23 Jul 24
4
Change in insider ownership
22 Jul 24
4
Change in insider ownership
18 Jul 24
4
Change in insider ownership
16 Jul 24
SC 13D/A
Carlyle Group Inc.
15 Jul 24
4
Change in insider ownership
12 Jul 24
4
Change in insider ownership
10 Jul 24
Financial summary
Quarter (USD) | Dec 23 | Oct 23 | Jul 23 | Apr 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Jan 23 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 119.50 mm | 119.50 mm | 119.50 mm | 119.50 mm | 119.50 mm | 119.50 mm |
Cash burn (monthly) | 10.13 mm | 14.53 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 69.59 mm | 99.81 mm | n/a | n/a | n/a | n/a |
Cash remaining | 49.91 mm | 19.69 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | 4.9 | 1.4 | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2024
96.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 259 |
Opened positions | 89 |
Closed positions | 60 |
Increased positions | 57 |
Reduced positions | 72 |
13F shares | Current |
---|---|
Total value | 2.50 tn |
Total shares | 64.69 mm |
Total puts | 109.50 k |
Total calls | 487.00 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
CG Carlyle Group Inc | 12.46 mm | $597.34 bn |
T. Rowe Price Investment Management | 9.70 mm | $464.98 mm |
Vanguard | 4.88 mm | $233.91 bn |
BLK Blackrock | 4.87 mm | $233.23 bn |
Rubric Capital Management | 2.40 mm | $115.06 bn |
ArrowMark Colorado | 2.35 mm | $112.53 bn |
STT State Street | 1.58 mm | $75.92 bn |
Dimensional Fund Advisors | 1.42 mm | $68.29 bn |
JPM JPMorgan Chase & Co. | 1.37 mm | $65.54 bn |
Maverick Capital | 1.36 mm | $65.02 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Jul 24 | Carlyle Group Inc | Common Stock | Sell | Dispose S | Yes | Yes | 39.1587 | 97,436 | 3.82 mm | 9,706,231 |
25 Jul 24 | Carlyle Group Inc | Common Stock | Sell | Dispose S | Yes | Yes | 38.4043 | 309,373 | 11.88 mm | 9,803,667 |
24 Jul 24 | Carlyle Group Inc | Common Stock | Sell | Dispose S | Yes | Yes | 39.3148 | 119,578 | 4.70 mm | 10,113,040 |
24 Jul 24 | Carlyle Group Inc | Common Stock | Sell | Dispose S | Yes | Yes | 38.5494 | 92,628 | 3.57 mm | 10,232,618 |
24 Jul 24 | Carlyle Group Inc | Common Stock | Sell | Dispose S | Yes | Yes | 37.9042 | 2,526 | 95.75 k | 10,325,246 |
23 Jul 24 | Carlyle Group Inc | Common Stock | Sell | Dispose S | Yes | Yes | 37.0242 | 5,839 | 216.18 k | 10,327,772 |
23 Jul 24 | Carlyle Group Inc | Common Stock | Sell | Dispose S | Yes | Yes | 36.5844 | 84,892 | 3.11 mm | 10,333,611 |
23 Jul 24 | Carlyle Group Inc | Common Stock | Sell | Dispose S | Yes | Yes | 35.5778 | 8,814 | 313.58 k | 10,418,503 |
22 Jul 24 | Carlyle Group Inc | Common Stock | Sell | Dispose S | Yes | Yes | 35.3292 | 129,039 | 4.56 mm | 10,427,317 |
22 Jul 24 | Carlyle Group Inc | Common Stock | Sell | Dispose S | Yes | Yes | 34.9597 | 6,202 | 216.82 k | 10,556,356 |
Press releases
Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600
23 Jul 24
QuidelOrtho to Report Second Quarter 2024 Financial Results
17 Jul 24
DEADLINE TODAY: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
11 Jun 24
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho
10 Jun 24
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)
10 Jun 24